90. Risk-taking and coping strategies of adolescents and young adults with food allergy. Margaret A. Sampson et al. J. Allergy Clin Immunol. Jun 2006.
91. Skin Prick Testing for the diagnosis of allergic didease. ASCIA a manual for practitioners, 2016.
92. Standardizing double-blind, placebo-controlled oral food challenges: American Academy of Allergy, Asthma & Immunology – European 172 ЕЛЕНА РООМЕТ Academy of Allergy and Clinical Immunology PRACTALL consensus report. Hugh A. Sampson et al.
93. Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis. Elaine C. Siegfried et al. BMC Pediatrics vol. 16, Article number: 75 (2016).
94. Testing children for allergies: why, how, who and when: an updated statement of the European Academy of Allergy and Clinical Immunology (EAACI) Section on Pediatrics and the EAACI–Clemens von Pirquet Foundation. Eigenmann et al. Pediatr Allergy Immunol. Mar 2013.
95. Testing for IgG4 against foods is not recommended as a diagnostic tool: EAACI Task Force Report Stapel S. O., Asero R., Ballmer-Weber B. K. et al. // Allergy. 2008. Vol. 63(7). Рр. 793–796.
96. The ability of adults and children to visually identify peanuts and tree nuts. Hostetler T. L., 2012.
97. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Zuberbier T. et al. Allergy. 2018.
98. The Effects of Early Nutritional Interventions on the Development of Atopic Disease in Infants and Children: The Role of Maternal Dietary Restriction, Breastfeeding, Hydrolyzed Formulas, and Timing of Introduction of Allergenic Complementary Foods. Frank R. Greer et al. Pediatrics. Apr 2019.
99. The effects of inhaled corticosteroids on growth in children. Jim Philip. Open Respir Med J. 2014.
100. The management of the allergic child at school: EAACI/GA2LEN Task Force on the allergic child at school. Muraro et al. 2010 Jun 1;65(6):681–9.
101. The role of sports and exercise in allergic disease: drawbacks and benefits. Diana Silva et al. Expert Rev. Clin. Immunol. Early online, 1–11 (2015).
102. The skin as a target for prevention of the atopic march. Adrian J. Lowe et al. Ann Allergy Asthma Immunol. Feb 2018.
103. Topical corticosteroids for pediatric atopic dermatitis: Thoughtful tips for practice. Andrea Chiricozzi, Pascale Combriati et al. Pharmacological Research, Volume 158, August 2020.
104. Treatment of atopic dermatitis (eczema), William L. Weston, MD et al. UpToDate. Apr 2021. This topic last updated: Apr 15, 2021.
105. Topical corticosteroids normalize both skin and systemic inflammatory markers in infant atopic dermatitis, M. A. McAleer et al. British Journal of Dermotology, Dec 2020.
106. Vaccination and allergy: EAACI position paper, practical aspects. Lennart Nilsson et al. Pediatr Allergy Immunol. Nov 2017.
107. Vaccination in children with allergy to non active vaccine components. Franceschini F. Et al. Clinical and Translational Medicine (2015) 4:3.
108. Vaccine-associated hypersensitivity. McNeill M. M., DeStefano F. J Allergy Clin Immunol 2018, 141:2.
109. What are the best types of exercise for asthma. UpToDate.
110. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow’s Milk Allergy (DRACMA) Guidelines. Alessandro Fiocchi et al. World Allergy Organ J. Apr 2010; 3(4): 57–161.
111. World Allergy Organization Anaphylaxis Guidance 2020. Victoria Cardonaa, Ignacio J. Ansoteguib, et al., World Allergy Organization J. Oct 2020.